Table 1.
Tat antibody responses before and after challenge.
The tat antibody responses were measured as end-point dilution titers in samples from individual macaques before the first challenge (90 days post booster immunization) and at the end of the trial (50 weeks post first challenge). Starting dilution was 1:200. A blank space denotes a titer of < 200.
| Vaccination status | Monkey ID | Status | Pre-challenge | End of trial |
|---|---|---|---|---|
| Vaccinated | IT22 | Protected | ||
| IA39 | Partially protected | |||
| IT19 | Protected | |||
| IH49 | Partially protected | 200 | ||
| IG98 | Partially protected | 400 | ||
| IJ60 | Not protected | 400 | 200 | |
| Not Vaccinated | IJ92 | Not protected | ||
| II39 | Not protected | |||
| IR98a | Not protected | |||
| IT06 | Not protected | |||
| HV04 | Not protected | |||
| IM44 | Not protected | 1600 |
a
The indicated macaque had its last blood samples drawn 28 weeks after the first challenge.